Shailesh Jain, MD

Department of Psychiatry, Texas Tech University, Permian Basin, Texas

  • 27Articles
  • 418KReads
  • 2007–2026Active
  • 71Collaborators
  • 100Citations

About

Shailesh Jain, MD, is affiliated with the Department of Psychiatry at Texas Tech University, Permian Basin, Texas. Since 2007, Jain has published extensively on topics including major depressive disorder, addiction, child and adolescent psychiatry, autism spectrum disorders, bipolar disorder, schizophrenia, and gender-related psychiatric issues. The author’s work encompasses clinical investigations into pharmacological treatments, psychiatric comorbidities, substance use disorders, and neurostimulation methods. Frequent collaborators include Zeeshan Mansuri, Chintan Trivedi, Kaushal Shah, Sahar Ashraf, and Ramu Vadukapuram.

Publications

PCC
Bupropion-Dextromethorphan for Clinically Challenging Apathy
Case Report

Bupropion-Dextromethorphan for Clinically Challenging Apathy

April 2, 2026

This case shows potential benefits of glutamate system–activating medication in addressing clinically challenging apathy in a 44-year-old man with depression.
, , , et al
PCC
Role of tDCS in Autism
Meta-Analysis

Role of tDCS in Autism

March 12, 2026

Transcranial direct current stimulation improves core autism spectrum disorder symptoms, particularly social responsiveness and behavioral regulation, with stimulation of the dorsolateral prefrontal cortex showing the greatest benefit.
, , , et al
PCC
Gender-Affirming Surgery, Gender Dysphoria, and QOL
Review Article

Gender-Affirming Surgery, Gender Dysphoria, and QOL

November 11, 2025

Those who receive gender dysphoria treatment at a younger age may experience lower rates of suicidal ideation, underscoring potential mental health benefits of timely intervention.
, , , et al
PCC
Amnesia Associated With Recreational Cannabis Use in an Adolescent
Case Report

Amnesia Associated With Recreational Cannabis Use in an Adolescent

September 16, 2025

A 17-year-old girl with no prior psychiatric or medical history presented to the psychiatry ED for confusion and agitation following recent cannabis use.
, , , et al
PCC
Role of GLP-1 Receptor Agonists in AUD
Narrative Review

Role of GLP-1 Receptor Agonists in AUD

May 15, 2025

The authors examine the potential benefits, dosages, and mechanisms of GLP-1 receptor agonists on alcohol consumption and how they can potentially modify alcohol-seeking behavior.
, , , et al
PCC
Substance Use in Pregnant and Postpartum Women
Brief Report

Substance Use in Pregnant and Postpartum Women

March 6, 2025

This study calculated the prevalence of substance use disorder diagnosis among pregnant and postpartum visits in 2020 using inpatient and ED data from the National Hospital Care Survey.
, , , et al
PCC
Psychiatric Comorbidities in Adolescents With Polycystic Ovary Syndrome
Original Research

Psychiatric Comorbidities in Adolescents With Polycystic Ovary Syndrome

November 7, 2024

PCOS symptoms extend beyond reproductive issues, with noted correlations to anxiety, depression, and suicidal attempts. This study assessed psychiatric comorbidities among hospitalized adolescent females with PCOS.
, , , et al
PCC
Relationship Between Social Isolation and Substance Abuse
Original Research

Relationship Between Social Isolation and Substance Abuse

September 24, 2024

This study highlights the connection between social isolation and substance use disorder, emphasizing the need to address social isolation as a public health issue.
, , , et al
PCC
Montelukast-Associated Psychosis in Children
Case Report

Montelukast-Associated Psychosis in Children

May 28, 2024

Two children experienced auditory visual hallucinations after taking montelukast for 1 to 2 days for asthma.
, , , et al
PCC
Camptocormia and Antipsychotic Medications
Brief Report

Camptocormia and Antipsychotic Medications

May 23, 2024

Camptocormia, or “bent spine syndrome,” is an often-overlooked adverse effect of antipsychotics; early diagnosis and treatment is essential to prevent severe consequences.
, , , et al
PCC
Phentermine–Induced Hypomania in Bipolar Depression
Case Report

Phentermine–Induced Hypomania in Bipolar Depression

February 20, 2024

The authors report a case of phentermine-induced mania/hypomania in a woman with bipolar depression who was stable on a mood stabilizer and antidepressant.
, ,
PCC
Fentanyl-Laced Marijuana Use in Adolescents [Retracted]
Letter to the Editor

Fentanyl-Laced Marijuana Use in Adolescents [Retracted]

February 6, 2024

, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe